Sort
50,496 grants matching “lung cancer”
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$590,778Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
$590,758Orly Alter · University Of Utah · U01 · FY2016 · CA
Integrated Informatic and Experimental Evaluations of Cancer Chronotherapy
$590,751Ron C. Anafi · University Of Pennsylvania · R01 · FY2020 · CA
Real time scattered x-ray imaging for tumor motion tracking in radiotherapy.
$590,726Xun Jia · Johns Hopkins University · R01 · FY2024 · CA
NYU Lung Cancer Biomarker Center
$590,723William N Rom · New York University School Of Medicine · U01 · FY2013 · CA
Restoring Salivary Gland Function by Reducing Nucleotide-induced Inflammation
$590,608Gary Andrew Weisman · University Of Missouri-Columbia · R01 · FY2014 · DE
ECOGENETICS OF LUNG CANCER
$590,605University Of Texas Md Anderson Can Ctr · R01 · FY2001 · CA
Infrastructure Support and Pilot Tissue Collection for the CARET Biorepository
$590,562Chu Chen · Fred Hutchinson Cancer Research Center · U01 · FY2020 · CA
A Phase II Trial of ACAPHA in Former Smokers with IEN.
$590,472Stephen C Lam · British Columbia Cancer Agency · U01 · FY2006 · CA
Percutaneous Ultrasound Gastrostomy: Clinical Evaluation of a Novel Method for Feeding Tube Placement
$590,458Howard Carolan · Coaptech, Llc · R44 · FY2020 · DK
MODELING THE POLICY IMPACT OF CIGARETTE AND SMOKELESS USE ON US MORTALITY
$590,436David T Levy · Georgetown University · R01 · FY2013 · DA
Promoting tumor cell apoptosis by death ligands
$590,400Thomas Sayers · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Natural Products with Selective Cytoxicity to Non Small Cell Lung Cancer
$590,349John D Minna · Ut Southwestern Medical Center · R01 · FY2019 · CA
The Duke Preclinical Research Resources for Quantitative Imaging Biomarkers
$590,346Cristian T Badea · Duke University · U24 · FY2019 · CA
Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications
$590,300Ramon C. Sun · University Of Florida · R01 · FY2025 · CA
Endothelial Toll-like Receptor 3 in the pathogenesis and therapy of Pulmonary Arterial Hypertension
$590,163Laszlo Farkas · Ohio State University · R01 · FY2020 · HL
Accountability for Cancer Care through Undoing Racism and Equity (ACCURE)
$590,152Eugenia Eng · Univ Of North Carolina Chapel Hill · R01 · FY2012 · CA
Reprogramming the pancreatic tumor microenvironment with immunotherapy
$590,123Lei Zheng · Johns Hopkins University · R01 · FY2019 · CA
Molecular and Genetic Analysis of Lung Cancer Survival
$590,122David C Christiani · Harvard School Of Public Health · R01 · FY2010 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$590,100Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2023 · CA
Application of molecular diagnostics in thyroid cancer
$590,067Joanna Klubo-Gwiezdzinska · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
CANCER RISKS AMONG TEXTILE WORKERS IN CHINA
$590,064Fred Hutchinson Cancer Research Center · R01 · FY2000 · CA
Sex Hormones in Pulmonary Arterial Hypertension
$590,009James E Loyd · Vanderbilt University Medical Center · P01 · FY2017 · HL
Local Flavor Policies to Enhance Equity in Tobacco
$589,990Shyanika W Rose · University Of Kentucky · R01 · FY2022 · CA
Communicating Waterpipe Tobacco Harms to Reduce Use among Young Adults
$589,886Erin L Sutfin · Wake Forest University Health Sciences · R01 · FY2020 · CA